TB-500: The Systemic Healing Peptide That Completes the Recovery Equation

What Is TB-500?

TB-500 is a synthetic version of thymosin beta-4, a naturally occurring 43-amino-acid peptide found in virtually every human cell. Thymosin beta-4 is one of the most abundant intracellular proteins in the body and plays a fundamental role in cell migration, blood vessel formation, and tissue repair.

Unlike BPC-157, which targets localized tissue repair at the site of injury, TB-500 operates systemically. When injected subcutaneously, it circulates throughout the body and promotes healing across multiple tissue types simultaneously. This systemic action makes it particularly valuable for individuals dealing with widespread inflammation, chronic injury patterns, or recovery demands that affect multiple body regions.

TB-500 was restored to Category 1 compounding status alongside BPC-157 in February 2026, meaning licensed physicians can now prescribe it through compounding pharmacies.

How TB-500 Works

TB-500 exerts its healing effects through several interconnected mechanisms that collectively reduce inflammation and accelerate tissue repair.

The peptide upregulates actin, a cell-building protein essential for cell migration and proliferation. By increasing actin production, TB-500 enables cells to move more rapidly to sites of damage, accelerating the body’s natural repair response. This enhanced cell motility is one of the primary mechanisms distinguishing TB-500 from other regenerative compounds.

TB-500 promotes angiogenesis — the formation of new blood vessels. Injured tissue requires robust blood supply to deliver oxygen, nutrients, and immune cells necessary for repair. By stimulating new blood vessel growth, TB-500 ensures damaged areas receive the resources needed for healing.

The peptide demonstrates significant anti-inflammatory properties through its interaction with inflammatory cytokines and immune cell signaling. Rather than suppressing the immune response entirely, TB-500 modulates inflammation, reducing excessive inflammatory activity while preserving the beneficial aspects of the immune response.

TB-500 also supports the formation of new muscle fibers and improves the flexibility of tendons and ligaments. Research has shown it promotes the differentiation of endothelial cells, keratinocytes, and muscle satellite cells — the precursor cells responsible for tissue regeneration.

Key Benefits

The systemic nature of TB-500 creates a broad benefit profile that extends across multiple body systems.

Whole-body inflammation reduction is the most distinctive benefit. While BPC-157 targets specific injury sites, TB-500 reduces inflammatory markers systemically. Users frequently report decreased joint stiffness, reduced chronic pain, and improved mobility across the entire body within the first 2-3 weeks.

Accelerated wound healing has been documented across multiple tissue types including muscle, tendon, ligament, skin, and even cardiac tissue. The peptide’s ability to promote cell migration and blood vessel formation creates favorable conditions for repair regardless of the tissue involved.

Improved flexibility and reduced scarring occur through TB-500’s effects on collagen deposition and tissue remodeling. The peptide promotes more organized tissue formation, resulting in more functional repair rather than rigid scar tissue.

Cardiovascular support has been observed in preclinical research, with thymosin beta-4 showing protective effects on cardiac tissue following injury. Studies have demonstrated reduced scar formation and improved cardiac function in animal models of heart damage.

Hair regrowth is an emerging area of interest, with research suggesting TB-500 may activate hair follicle stem cells and promote the transition from resting to growth phase.

Dosing Protocol

TB-500 is typically administered in two distinct phases: a loading phase and a maintenance phase.

The loading phase runs for the first 4-6 weeks and involves higher doses to establish therapeutic levels. Typical loading doses range from 2 to 2.5mg administered subcutaneously twice per week. Some physicians prescribe doses as high as 5mg twice weekly for severe or chronic conditions.

The maintenance phase follows loading and uses reduced dosing to sustain benefits. Typical maintenance doses are 2 to 2.5mg once per week or every two weeks, depending on the individual’s response and treatment goals.

TB-500 is supplied as a lyophilized powder, typically in 5mg vials. It must be reconstituted with bacteriostatic water before injection. Our Dose Calculator handles the reconstitution math automatically for your specific vial size and target dose.

Injection site is less critical for TB-500 than for BPC-157 because TB-500 works systemically. Subcutaneous injection in the abdomen is the most common approach, though any subcutaneous site is acceptable.

The BPC-157 + TB-500 Recovery Stack

The combination of BPC-157 and TB-500 represents the gold standard recovery protocol in longevity medicine. The two peptides complement each other through fundamentally different mechanisms.

BPC-157 excels at localized, targeted tissue repair. It works best when injected near the site of injury, activating growth factors and blood vessel formation at that specific location. Its effects are concentrated and precise.

TB-500 provides systemic support. It circulates throughout the body, reducing inflammation everywhere, promoting healing across all tissue types simultaneously, and creating a broadly favorable environment for recovery.

Together, they address both the specific injury and the systemic inflammatory environment surrounding it. The local precision of BPC-157 combined with the whole-body support of TB-500 produces faster, more complete recovery than either peptide alone.

At Longevity AI, the Recovery Stack pairs BPC-157 (250mcg twice daily) with TB-500 (2.5mg twice weekly) in a physician-supervised 4-12 week protocol. Physician-supervised protocols are coming soon — explore the Compound Wiki and Dose Calculator to start planning.

Research Summary

Thymosin beta-4 has been studied extensively, with research published in journals including the Annals of the New York Academy of Sciences, the FASEB Journal, and Wound Repair and Regeneration.

Clinical research has demonstrated TB-500’s effects on corneal wound healing, with studies showing accelerated repair of corneal tissue following injury. Research in cardiac models has shown protective effects on heart tissue, with thymosin beta-4 reducing scar formation and improving contractile function.

Preclinical studies have documented enhanced healing in skin wounds, muscle injuries, tendon damage, and ligament tears. The consistency of results across tissue types supports the systemic mechanism of action.

As with BPC-157, most TB-500 research has been conducted in preclinical models. Physician supervision ensures appropriate monitoring and protocol adjustment based on individual response.

Getting Started

Our Recovery Stack protocol is the most popular entry point for TB-500 access. Take the Health Quiz to see if recovery and inflammation reduction align with your goals, or ask our AI advisor about specific questions regarding TB-500 and how it pairs with your current health situation. Your physician will customize the loading and maintenance protocol based on your individual needs.